SofWave Medical Statistics
Total Valuation
SofWave Medical has a market cap or net worth of ILS 1.03 billion. The enterprise value is 947.10 million.
| Market Cap | 1.03B |
| Enterprise Value | 947.10M |
Important Dates
The last earnings date was Tuesday, November 4, 2025.
| Earnings Date | Nov 4, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SofWave Medical has 35.69 million shares outstanding. The number of shares has increased by 11.84% in one year.
| Current Share Class | 35.69M |
| Shares Outstanding | 35.69M |
| Shares Change (YoY) | +11.84% |
| Shares Change (QoQ) | +1.26% |
| Owned by Insiders (%) | 34.90% |
| Owned by Institutions (%) | 24.57% |
| Float | 16.70M |
Valuation Ratios
The trailing PE ratio is 454.59.
| PE Ratio | 454.59 |
| Forward PE | n/a |
| PS Ratio | 4.04 |
| PB Ratio | 11.10 |
| P/TBV Ratio | 11.10 |
| P/FCF Ratio | 63.34 |
| P/OCF Ratio | 59.33 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 64.26, with an EV/FCF ratio of 58.27.
| EV / Earnings | 418.18 |
| EV / Sales | 3.71 |
| EV / EBITDA | 64.26 |
| EV / EBIT | 109.38 |
| EV / FCF | 58.27 |
Financial Position
The company has a current ratio of 2.37, with a Debt / Equity ratio of 0.05.
| Current Ratio | 2.37 |
| Quick Ratio | 2.05 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | 0.31 |
| Debt / FCF | 0.28 |
| Interest Coverage | 5.15 |
Financial Efficiency
Return on equity (ROE) is 2.62% and return on invested capital (ROIC) is 5.96%.
| Return on Equity (ROE) | 2.62% |
| Return on Assets (ROA) | 3.78% |
| Return on Invested Capital (ROIC) | 5.96% |
| Return on Capital Employed (ROCE) | 8.99% |
| Revenue Per Employee | 2.02M |
| Profits Per Employee | 17,975 |
| Employee Count | 126 |
| Asset Turnover | 1.78 |
| Inventory Turnover | 3.57 |
Taxes
In the past 12 months, SofWave Medical has paid 2.08 million in taxes.
| Income Tax | 2.08M |
| Effective Tax Rate | 47.83% |
Stock Price Statistics
The stock price has increased by +49.02% in the last 52 weeks. The beta is 0.70, so SofWave Medical's price volatility has been lower than the market average.
| Beta (5Y) | 0.70 |
| 52-Week Price Change | +49.02% |
| 50-Day Moving Average | 2,815.36 |
| 200-Day Moving Average | 2,185.31 |
| Relative Strength Index (RSI) | 47.33 |
| Average Volume (20 Days) | 64,770 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SofWave Medical had revenue of ILS 255.13 million and earned 2.26 million in profits. Earnings per share was 0.06.
| Revenue | 255.13M |
| Gross Profit | 192.32M |
| Operating Income | 8.66M |
| Pretax Income | 4.34M |
| Net Income | 2.26M |
| EBITDA | 13.31M |
| EBIT | 8.66M |
| Earnings Per Share (EPS) | 0.06 |
Balance Sheet
The company has 86.95 million in cash and 4.50 million in debt, giving a net cash position of 82.45 million or 2.31 per share.
| Cash & Cash Equivalents | 86.95M |
| Total Debt | 4.50M |
| Net Cash | 82.45M |
| Net Cash Per Share | 2.31 |
| Equity (Book Value) | 92.77M |
| Book Value Per Share | 2.61 |
| Working Capital | 81.23M |
Cash Flow
In the last 12 months, operating cash flow was 17.35 million and capital expenditures -1.10 million, giving a free cash flow of 16.25 million.
| Operating Cash Flow | 17.35M |
| Capital Expenditures | -1.10M |
| Free Cash Flow | 16.25M |
| FCF Per Share | 0.46 |
Margins
Gross margin is 75.38%, with operating and profit margins of 3.39% and 0.89%.
| Gross Margin | 75.38% |
| Operating Margin | 3.39% |
| Pretax Margin | 1.70% |
| Profit Margin | 0.89% |
| EBITDA Margin | 5.22% |
| EBIT Margin | 3.39% |
| FCF Margin | 6.37% |
Dividends & Yields
SofWave Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -11.84% |
| Shareholder Yield | -11.84% |
| Earnings Yield | 0.22% |
| FCF Yield | 1.58% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SofWave Medical has an Altman Z-Score of 6.96 and a Piotroski F-Score of 6.
| Altman Z-Score | 6.96 |
| Piotroski F-Score | 6 |